The Science of Ultrasound Renal Denervation

  • Views:

    Views Icon 6322
  • Likes:

    Heart Icon 4


Why use ultrasound for Renal Denervation (RDN)?   

The Science of Ultrasound Renal Denervation brings together four experts to introduce ultrasound renal denervation technology.  This one-hour educational program walks you through the core concepts and the pre-clinical evidence used to refine the design that led to the ultrasound renal denervation technology.     

If you have watched the on-demand video we would be most grateful if you could complete a short survey.  To take part please click HERE


Performed By:

Philipp Lurz

Philipp Lurz

Michael Joner

Michael Joner

Felix Mahfoud

Felix Mahfoud

Andrew Wu

Andrew Wu

This webinar is supported by:


16:00 - 16:05

Introduction of ultrasound renal denervation technology
Prof Philipp Lurz

16:05 - 16:15

Ultrasound technology - its development and unique characteristics
Mr Andrew Wu

16:15 - 16:30

Pre-clinical evidence (Histopathology)
Prof Michael Joner

16:30 - 16:45

RDN procedure with ultrasound technology
Prof Felix Mahfoud

16:45 - 17:00

Panel discussion and closing remarks
All faculty

Learning Objectives

  • Understand the mechanism of action of ultrasound denervation technology
  • Learn the scientific rationales behind the design of ultrasound technology for RDN
  • Learn the pre-clinical evidence and histopathology of ultrasound renal denervation
  • Hear expert discussions and takeaways

Target Audience

  • Interventional Cardiologists
  • Hypertension Specialists
  • Primary Care Physicians
  • General Cardiologists

Faculty Biographies

Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Luz is widely published in leading international peer-reviewed journals.

View full profile
Michael Joner

Michael Joner

Dr Michael Joner MD is the head, preclinical research, German Heart Centre, Munich and CEO, CVPath Institute, Gaithersburg, MaryLand. He completed his medical training at the University of Wuerzburg and spent 2004-2006 as a cardiovascular pathology fellow at the CVPath Institute.  After returning to Germany, since 2007 Dr. Joner has been Head of the Preclinical Research at the German Heart Center in Munich, where he also completed his interventional cardiology residency. 

View full profile
Felix Mahfoud

Felix Mahfoud

Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Professor Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.

View full profile
Andrew Wu

Andrew Wu

Vice President, Research & Development, ReCor Medical

Mr. Wu has over 20 years of experience in medical device product development. He has worked on devices in the fields of interventional cardiology, electrophysiology, pulmonology, and women’s health, and has taken a number of them from early concept phase through clinical or commercial launch.

View full profile